Opioid Induced Constipation Lisa Clince Acute Pain CNS Palmerston North Hospital

Similar documents
Constipation an Old Friend. Presented by Dr. Keith Harris

Constipation An Overview. Definition Physiology of GI tract Etiology Assessment Treatment

Constipation. What is constipation? What is the criteria for having constipation? What are the different types of constipation?

Constipation and bowel obstruction

Constipation Information Leaflet THE DIGESTIVE SYSTEM. gutscharity.org.uk

CONSTIPATION. Atan Baas Sinuhaji

Drugs Affecting the Gastrointestinal System. Antidiarrheal and Laxatives

Constipation. (Medical Aspects)

Developing spinal cord compression care guidelines at WPH

Aging Persons with Intellectual Developmental Disorders (IDD): Constipation KEYPOINTS OVERVIEW

GI Pharmacology -4 Irritable Bowel Syndrome and Antiemetics. Dr. Alia Shatanawi

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

Opioid-Induced Constipation

OPIOID-INDUCED CONSTIPATION DR ANDREW DAVIES

Understanding & Alleviating Constipation. Living (Well!) with Gastroparesis Program Warm-Up Class

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

What Is Constipation?

Elderly Man With Chronic Constipation

Introductory Clinical Pharmacology Chapter 32 Antiparkinsonism Drugs

Prescribing Guidance for the Treatment of Constipation in Children

Identify electrolytes that should be monitored whenever prolonged or severe diarrhea is present

Irritable Bowel Syndrome. Mustafa Giaffer March 2017

Treat primary. symptoms. Offer general lifestyle advice. Manage IBS according to the dominant symptom. Follow up. Symptoms do not improve

encathopedia Volume 8 NEUROGENIC BOWEL DYSFUNCTION AND TAI

Primary Management of Irritable Bowel Syndrome

Constipation. Disease Review

Chapter 19. Assisting With Bowel Elimination. Elsevier items and derived items 2014, 2010 by Mosby, an imprint of Elsevier Inc. All rights reserved.

Protocol to support reducing the use of and the effective use of laxatives. HaRD CCG employed Pharmacists and Medicines Optimisation Technicians.

Developing spinal cord compression care guidelines at WPH

What is Dietary Fibre?

Primary Care Constipation Guidelines. Version 1 November 2016

Lower Urinary Tract Symptoms (LUTS) and Nurse-Led Clinics. Sean Diver Urology Advanced Nurse Practitioner candidate Letterkenny University Hospital

Pharmacy Benefit Determination Policy

CONSTIPATION FUNDING RESEARCH INTO DISEASES OF THE GUT, LIVER & PANCREAS

Authors and Disclosures

GI Physiology - Investigating and treating patients with pelvic floor dysfunction. Lynne Smith Department of GI Physiology NGH Sheffield

SYMPROIC (naldemedine tosylate) oral capsule

Chapter 22. Bowel Needs. Copyright 2019 by Elsevier, Inc. All rights reserved.

MOVICOL Liquid Orange Flavour Concentrate for Oral Solution (macrogol 3350)

MOVICOL Lemon-Lime Flavour Powder for Solution (macrogol 3350)

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

Continence Promotion in

Antidiarrheals Antidiarrheal

3D Dynamic Ultrasound In Obstructed Defecation

Opioid-induced constipation a preventable problem

Pelvic Floor Therapy for the Neurologic Client Carina Siracusa, PT, DPT, WCS

Constipation. Information for adults. GI Motility Clinic (UMCCC University Medical Clinics of Campbelltown and Camden) Page 1

Morning Report S a p n a P a t e l K u e h l M D F A C P S t. A g n e s H o s p i t a l, B a l t i m o r e M D

Management of Neurogenic Bowel Dysfunction. Fiona Paul, DNP, RN, CPNP Center for Motility and Functional Gastrointestinal Disorders

MOVICOL HALF PI December MOVICOL-Half. Powder for Solution (macrogol 3350) Potassium 5.4 mmol/l. Bicarbonate 17 mmol/l

MOVICOL Junior Powder for Solution (macrogol 3350)

DOCTOR DISCUSSION GUIDE

Episode 3.2 Show Notes Constipation

Fecal Incontinence. What is fecal incontinence?

Nclex para la Enfermera Hispana

The commonest persistent side-effects are:

The Use of Antidepressants in the Treatment of Irritable Bowel Syndrome and Other Functional GI Disorders What are functional GI disorders?

CONTINENCE MODULE 3 MIMIMUM STANDARDS FOR SPECIALIST ASSESSMENT & CONSERVATIVE MANAGEMENT OF CONSTIPATION AND FAECAL INCONTINENCE

Continence/Constipation Workshop for RNs in Long-Term Care

Daniel Canafax, PharmD VP, Clinical Research Theravance, Inc.

Guideline scope Diverticular disease: diagnosis and management

SUMMARY OF THE PRODUCT CHARACTERISTICS. The content of electrolyte ions per sachet when made up to 125 ml of solution.

Human Anatomy rectum

Chapter 31 Bowel Elimination

2 QUALITATIVE AND QUANTITATIVE COMPOSITION

Scoop on the poop: Constipation in the Elderly

Patient Information Leaflet

Managing constipation in adults with co-morbidities

SUMMARY OF PRODUCT CHARACTERISTICS. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each sachet contains the following active ingredients:

Neuro Basics SLO Practice (online) Page 1 of 5

Summary of the risk management plan (RMP) for Moventig (naloxegol)

Paediatric constipation and functional non-retentive faecal soiling Voskuijl, W.P.

Oral Methylnaltrexone for the. Constipation in Patients with Chronic Non-cancer Pain

MOVICOL Junior Chocolate Flavour Powder for Solution (macrogol 3350)

Nursing Principles & Skills II. Bowel Sounds Constipation Fecal Impaction

Colectomy. Surgical treatment for Ulcerative Colitis (UC) and Familial Adenomatous Polyposis (FAP) Patient and Family Education

STOPP and START criteria October 2011

UNDERSTANDING IBS AND CC Implications for diagnosis and management

Immodium / loprarmide

Clinical problems related to GI involvement in SSc

CATEGORIES: QUIZ 2. Drugs Categories. 1. What drug subcategory often ends with the suffix -asone?

Multimodal Approach for Managing Postoperative Ileus: Role of Health- System Pharmacists (ACPE program H01P)

Use of Functional Electrical Stimulation (FES) for chronic constipation & People with Multiple Sclerosis (PwMS)

The Digestive System or tract extends from the mouth to the anus.

Constipation in children

Appendix E: Continence Care and Bowel Management Program Training Presentation. Audience: For Registered Staff Release Date: December 22, 2010

ALVIMOPAN 0.0 OVERVIEW

Nausea and Vomiting in Palliative Care

ABC of palliative care: Constipation and diarrhoea

STOPP START Toolkit Supporting Medication Review in the Older Person

Analgesia for Patients with Substance Abuse Disorders. Lisa Jennings CN November 2015

Nursing diagnosis for diverticular disease

Hypertension Update. Objectives 4/28/2015. Beverly J. Mathis, D.O. OOA May 2015

NEW ZEALAND DATA SHEET ACUPAN TM. 3. PHARMACEUTICAL FORM White, round, biconvex, film-coated tablets (7 mm diameter) engraved APN on one face.

Opioids and the Gastroenterologist: A Painful Issue

DIETARY ADVICE FOR CONSTIPATION

Theravance Announces Positive Results from Phase 1 and Phase 2 Clinical Studies with TD-1211 in Development for Opioid-Induced Constipation

MEDICATION GUIDE Oxycodone Hydrochloride (ox-ee-co-dohn) (CII) Oral Solution, USP

Horizon Scanning Technology Summary. Methylnaltrexone for opioid induced constipation in advanced illness and palliative care

1/3/2008. Karen Burke Priscilla LeMone Elaine Mohn-Brown. Medical-Surgical Nursing Care, 2e Karen Burke, Priscilla LeMone, and Elaine Mohn-Brown

Transcription:

Opioid Induced Constipation Lisa Clince Acute Pain CNS Palmerston North Hospital 21-04-2016 MidCentral District Health Board 1

Overview Patient Experience Opioid Collaborative Constipation defined Opioid Induced Constipation 21-04-2016 MidCentral District Health Board 2

Clinical Experience Discuss a clinical experience related to constipation.. What impact did this have on the person Reflect on your feelings and actions in this situation.. 21-04-2016 MidCentral District Health Board 3

Violet s Story Learning Points Co-prescribing laxatives with opioid Targeted patient education can never be underestimate Description of bowel movement Treat constipation promptly & prior to discharge LISTEN to the patient 21-04-2016 MidCentral District Health Board 4

Opioid Collaborative The Commission is partnering with District Health Boards in implementing a national Collaborative on the Safe Use of Opioids in DHB hospitals to reduce opioid related harms. Aim: We aim to reduce the harm related to opioid use nationally by 25% in all the participating areas of District Health Board hospitals by June 2016. DHB Aim: MidCentral DHB will reduce opioid related constipation from 13% (baseline) by 50% to 6.5% in Star 2 by June 2016. 21-04-2016 MidCentral District Health Board 5

Constipation Definition Constipation is defined as bowels have not opened for 3 days 21-04-2016 MidCentral District Health Board 6

Constipation Definition Constipation is a decrease in frequency of bowel movements from what is normal for the individual; hard, difficult-to-pass stools; a decrease in stool volume; and retention of faeces in the rectum. Normal bowel elimination may vary from three times a day to once every three days ( Norton & Chelvanayagam. 2000). 21-04-2016 MidCentral District Health Board 7

Clinical Manifestations Abdominal: pain, discomfit, distension Decreased frequency Hard dry stools Staining Rectal pressure Tenesmus Increased flatulence Nausea Anorexia Headache Dizziness Increased lassitude Emotional irritation Urinary retention Palpable mass 21-04-2016 MidCentral District Health Board 8

Four Main Physiological Causes of Constipation Slow Transit Time Altered Faecal Composition Decreased ability to evacuate bowels Altered ability to recognise urge to pass a stool 21-04-2016 MidCentral District Health Board 9

Colonic Disorders Obstructing lesions Inflammatory strictures Vovulus Intussusception Irritable bowel syndrome Diverticular disease Rectocele 21-04-2016 MidCentral District Health Board 10

Drug Induced Opioids - Morphine Antiemetics - Ondansetron Psychotropics/nueroleptics-Olanzapine Antidepressants Amitriptyline Anticholinergics Hyoscine butlybromide Beta blockers - Metoprolol Antihyperglycaemic - Metformin Monomine Oxidase Inhibitors - Moclobemide Calcium Channel Antagonists -Verapamil Antihypertensive - Clonidine 21-04-2016 MidCentral District Health Board 11

Systemic Disorders Collagen vascular disease Scleroderma Amyloidosis Neurogenic disorders Hirschsprung s megacolon Autonomic neuropathy (pseudo-obstruction) Multiple Sclerosis Parkinson's disease CVA Spinal cord lesions or injury 21-04-2016 MidCentral District Health Board 12

Systemic Disorders Metabolic/endocrine Diabetes mellitus Hypothyroidism Pregnancy Hypercalcemia/hyper-parathyroidism Pheochromocytoma 21-04-2016 MidCentral District Health Board 13

What are opioids? Opioids are a class of drugs that are commonly prescribed for their analgesic, or pain-killing, properties. Opioids bind to specific opioid receptors opioid in the nervous system and other tissues. There are three principal classes of opioid receptors mu, kappa, and delta Opioids also bind to mu receptors in the gut which leads to slowed gut contractility and therefore increased transit time. Consequently, stools will become hard and drier. 21-04-2016 MidCentral District Health Board 14

Opioid Induced Constipation Constipation is a known side effect of opioid analgesics and should be addressed before opioid therapy begins. As opioid-induced constipation can be severe and adversely impact quality of life and compliance with therapy. 21-04-2016 MidCentral District Health Board 15

Clinical Experience What suggestion do you have that could minimize the impact of OIC Please write your ideas on post it and place on board 21-04-2016 MidCentral District Health Board 16

Interventions to treat OIC Prophylaxis with laxatives Patient/family education and discussion Changing lifestyle factors : Increasing dietary fiber Increasing fluid intake Increasing exercise or physical activity Increasing time and privacy for toileting 21-04-2016 MidCentral District Health Board 17